Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2021
Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombiCédric Duval, Adomas Baranauskas, Tímea Feller, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding ModeVineet Pande, Weimei Sun, Lijs Beke, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
The Journal of Biological Chemistry|March 22, 2018
Probing the quality control mechanism of the Escherichia coli twin-arginine translocase with folding variants of a de novo-designed heme proteinGeorge A Sutherland, Katie J Grayson, Nathan B P Adams, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1)Mark Bell, David Foley, Claire Naylor, et al.
RSC Medicinal Chemistry|January 8, 2026
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferaseIrene Georgiou, Colin Robinson, Sean N O'Byrne, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 ReplicationDorothée Bardiot, Laura Vangeel, Mohamed Koukni, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signalingMark Zak, Emily J Hanan, Patrick Lupardus, et al.
Pageof 17